Skip to main content

COVID-19 Topic Center

Psoriasis News

News
Between 2013 and 2017, the proportion of Medicare Part D spending on psoriasis drugs grew from 36% to 53% of total dermatology-related spending, according to a study published online ahead of print in the Journal of Dermatological Treatment. “Over the past decade, many new biologic and small-…
News
Patients with psoriasis, and to a lesser extent those with psoriatic arthritis, who use methotrexate have a higher risk of liver disease than patients with rheumatoid arthritis who use the immunosuppressant, according to a study published online ahead of print in the Journal of the American Academy…
News
Patients who initiated oral immunotherapy to treat psoriasis, psoriatic arthritis, and rheumatoid arthritis were more likely to switch medications and had increased outpatient health care use compared with patients who initiated injectable immunotherapy, according to a study published in the…
News
Therapeutic blockage of the pro-inflammatory cytokine interleukin-17A could exacerbate fungal infections in patients with several autoimmune diseases such as psoriasis and psoriatic arthritis, according to a review article published online in the journal Giornale Italiano di Dermatologia e…
News
Although the minimum eligibility for psoriasis treatment is typically a Psoriasis Area and Severity Index (PASI) score of 10 or 12, which is considered moderate psoriasis, patients with lower scores can still have major quality of life impairment, according to a study published online in the…
News
Patients with psoriasis have a significantly higher comedication burden compared with the general population, according to a study published online in the journal Dermatology and Therapy. “The level of comedication found in the present study reinforces the evidence of the high comorbidity load…
News
US patients hospitalized for psoriasis had high rates of hospital readmission overall, but low rates of readmission for psoriasis specifically, according to a study published in the Journal of the American Academy of Dermatology. The study was an analysis of data from the 2012 to 2014 Nationwide…
News
A network meta-analysis spanning 11 biologic therapies for the treatment of psoriasis found comparable short-term efficacy and tolerability among most agents. Researchers published their findings online in the British Journal of Dermatology.  “Using our methodology, we find most biologics cluster…
News
Adults with psoriasis and three or more related comorbidities had more than $18,000 in additional annual health care costs than adults without psoriasis but with multiple comorbidities, according to a study published in the Journal of Medical Economics. “Healthcare resource use and cost burden of…
News
When it comes to selecting a biologic to treat psoriasis, patient response and patient-reported outcomes weigh heavily in treatment decisions, according to a study published online in the Journal of the American Academy of Dermatology. “Psoriasis Area and Severity Index (PASI) is most important…
Back to Top